Differential activation of the HCO<sub>3</sub><sup>‐</sup>conductance through the cystic fibrosis transmembrane conductance regulator anion channel by genistein and forskolin in murine duodenum

Biguang Tuo(Zunyi Medical University), Ursula Seidler(Medizinische Hochschule Hannover), Guorong Wen(Zunyi Medical University)
British Journal of Pharmacology
September 25, 2009
10.1111/j.1476-5381.2009.00398.x
Cited by 21

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
|PLoS ONE|2007|478
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2017|449
Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II
|Science|1996|409